litlas
Log inCreate account

Thomas B. Cooper

Active 1973–2020

Also published as
THOMAS B. COOPER · Thomas B Cooper
95
Papers
19,541
Citations
80
h-index
95
i10-index

Citations

Citations per year for Thomas B. Cooper1962: 1 citations1976: 1 citations1977: 1 citations1980: 1 citations1981: 1 citations1982: 2 citations1983: 1 citations1985: 1 citations1986: 5 citations1987: 3 citations1988: 8 citations1989: 4 citations1990: 11 citations1991: 15 citations1992: 12 citations1993: 31 citations1994: 11 citations1995: 26 citations1996: 25 citations1997: 38 citations1998: 62 citations1999: 78 citations2000: 84 citations2001: 106 citations2002: 135 citations2003: 189 citations2004: 204 citations2005: 268 citations2006: 283 citations2007: 259 citations2008: 260 citations2009: 276 citations2010: 250 citations2011: 245 citations2012: 224 citations2013: 199 citations2014: 193 citations2015: 168 citations2016: 169 citations2017: 129 citations2018: 109 citations2019: 385 citations2020: 361 citations2021: 349 citations2022: 245 citations2023: 157 citations2024: 234 citations2025: 74 citations2026: 2 citations1963–1975: no citations, so these years are not shown1978–1979: no citations, so these years are not shown1984: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,617 citing papers, 37.1% of this breakdownUnited Kingdom: 711 citing papers, 10.1% of this breakdownCanada: 511 citing papers, 7.3% of this breakdownGermany: 391 citing papers, 5.5% of this breakdownAustralia: 273 citing papers, 3.9% of this breakdownItaly: 264 citing papers, 3.7% of this breakdownNetherlands: 219 citing papers, 3.1% of this breakdownChina: 188 citing papers, 2.7% of this breakdownFrance: 161 citing papers, 2.3% of this breakdownSpain: 159 citing papers, 2.3% of this breakdownJapan: 144 citing papers, 2% of this breakdownSweden: 118 citing papers, 1.7% of this breakdown
0%37.1%Other 18.3%

Institutions

Fields

  • Medicine54.9%
  • Neuroscience27.2%
  • Psychology9.2%
  • Biochemistry, Genetics and Molecular Biology5.8%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Environmental Science0.4%
  • Other1.8%

Topics

  • Neurotransmitter Receptor Influence on Behavior8.1%
  • Schizophrenia research and treatment6.7%
  • Cannabis and Cannabinoid Research5.2%
  • Treatment of Major Depression5%
  • Tryptophan and brain disorders5%
  • Neuroscience and Neuropharmacology Research4.8%
  • Other65.2%

Coauthors

All papers

Open in search
  1. The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

    Authors: Deepak Cyril D’Souza, Edward Perry, Lisa Macdougall, Yola Ammerman, Thomas B. Cooper, Yu‐Te Wu, Gabriel Braley, Ralitza Gueorguieva, John H. Krystal - Neuropsychopharmacology 2004 cited by 1,027

  2. Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia

    Authors: Lawrence S. Kegeles, Anissa Abi‐Dargham, W. Gordon Frankle, Roberto Gil, Thomas B. Cooper, Mark Slifstein, Dah‐Ren Hwang, Yiyun Huang, Suzanne N. Haber, Marc Laruelle - Archives of General Psychiatry 2010 cited by 565

  3. Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam‐controlled randomized clinical trial

    Authors: Michael F. Grunebaum, Steven P. Ellis, John G. Keilp, Vivek K. Moitra, Thomas B. Cooper, Julia E. Marver, Ainsley K. Burke, Matthew S. Milak, M. Elizabeth Sublette, María A. Oquendo, J. John Mann - Bipolar Disorders 2017 cited by 174

  4. Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

    Authors: Deepak Cyril D’Souza, Walid Abi‐Saab, Steven Madonick, Kimberlee Forselius-Bielen, Anne Doersch, Gabriel Braley, Ralitza Gueorguieva, Thomas B. Cooper, John H. Krystal - Biological Psychiatry 2005 cited by 612

  5. Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia

    Authors: Anissa Abi‐Dargham, Janine Rodenhiser, David Printz, Yolanda Zea‐Ponce, Roberto Gil, Lawrence S. Kegeles, Richard M. Weiss, Thomas B. Cooper, J. John Mann, Ronald L. Van Heertum, Jack M. Gorman, Marc Laruelle - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 1,015

  6. Imaging Human Mesolimbic Dopamine Transmission With Positron Emission Tomography. Part II: Amphetamine-Induced Dopamine Release in the Functional Subdivisions of the Striatum

    Authors: Diana Martínez, Mark Slifstein, Allegra Broft, Osama Mawlawi, Dah‐Ren Hwang, Yiyun Huang, Thomas B. Cooper, Lawrence S. Kegeles, Eric Zarahn, Anissa Abi‐Dargham, Suzanne N. Haber, Marc Laruelle - Journal of Cerebral Blood Flow & Metabolism 2003 cited by 560

  7. Continuation Pharmacotherapy in the Prevention of Relapse Following Electroconvulsive Therapy

    Authors: Harold A. Sackeïm, Roger F. Haskett, Benoit H. Mulsant, Michael E. Thase, J. John Mann, Helen M. Pettinati, R. M. Greenberg, Raymond R. Crowe, Thomas B. Cooper, Joan Prudic - JAMA 2001 cited by 689

  8. Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis

    Authors: Deepak Cyril D’Souza, Mohini Ranganathan, Gabriel Braley, Ralitza Gueorguieva, Zoran Zimolo, Thomas B. Cooper, Edward Perry, John H. Krystal - Neuropsychopharmacology 2008 cited by 261

  9. Atypical Antipsychotic Agents in the Treatment of Violent Patients With Schizophrenia and Schizoaffective Disorder

    Authors: Menahem Krakowski, Pál Czobor, Leslie Citrome, Nigel Bark, Thomas B. Cooper - Archives of General Psychiatry 2006 cited by 354

  10. Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine

    Authors: Briana K. Chen, Victor M. Luna, Christina T. LaGamma, Xiaoming Xu, Shi‐Xian Deng, Raymond F. Suckow, Thomas B. Cooper, Abhishek Shah, Rebecca A. Brachman, Indira Mendez‐David, Denis J. David, Alain M. Gardier, Donald W. Landry, Christine A. Denny - Neuropsychopharmacology 2020 cited by 71

  11. Relationships between inflammatory markers and suicide risk status in major depression

    Authors: Licínia Ganança, Hanga Galfalvy, Sebastian Cisneros-Trujillo, Zahra Basseda, Thomas B. Cooper, Xinguo Ren, Maria Luísa Figueira, María A. Oquendo, J. John Mann, M. Elizabeth Sublette - Journal of Psychiatric Research 2020 cited by 42

  12. Ketamine metabolite pilot study in a suicidal depression trial

    Authors: Michael F. Grunebaum, Hanga Galfalvy, Tse‐Hwei Choo, Michelle S. Parris, Ainsley K. Burke, Raymond F. Suckow, Thomas B. Cooper, J. John Mann - Journal of Psychiatric Research 2019 cited by 40

  13. Circadian Time of Morning Light Administration and Therapeutic Response in Winter Depression

    Authors: Jiuan Su Terman, Michael Terman, Ee‐Sing Lo, Thomas B. Cooper - Archives of General Psychiatry 2001 cited by 369

  14. Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol on Hostility Among Patients With Schizophrenia

    Authors: Leslie Citrome, Jan Volavka, Pál Czobor, Brian Sheitman, Jean-Pierre Lindenmayer, Joseph P. McEvoy, Thomas B. Cooper, Miranda Chakos, Jeffrey A. Lieberman - Psychiatric Services 2001 cited by 202

  15. Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression

    Authors: Matthew S. Milak, Rain Rashid, Zhengchao Dong, Lawrence S. Kegeles, Michael F. Grunebaum, R. Todd Ogden, Xuejing Lin, Stephanie Mulhern, Raymond F. Suckow, Thomas B. Cooper, John G. Keilp, Xiangling Mao, Dikoma C. Shungu, J. John Mann - JAMA Network Open 2020 cited by 59

  16. Cerebrospinal Fluid Vasopressin Levels

    Authors: Emil F. Coccaro, Richard J. Kavoussi, Richard L. Hauger, Thomas B. Cooper, Craig F. Ferris - Archives of General Psychiatry 1998 cited by 395

  17. Positron Emission Tomography of Regional Brain Metabolic Responses to a Serotonergic Challenge and Lethality of Suicide Attempts in Major Depression

    Authors: María A. Oquendo, Giovanni P. A. Placidi, Kevin Malone, Carl E. Campbell, John G. Keilp, Beth Brodsky, Lawrence S. Kegeles, Thomas B. Cooper, Ramin V. Parsey, Ronald L. Van Heertum, J. John Mann - Archives of General Psychiatry 2003 cited by 314

  18. A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder

    Authors: Matthew S. Milak, Carol J. Proper, Stephanie Mulhern, A L Parter, Lawrence S. Kegeles, R. Todd Ogden, Xiangling Mao, Carolyn I. Rodríguez, María A. Oquendo, Raymond F. Suckow, Thomas B. Cooper, John G. Keilp, Dikoma C. Shungu, J. John Mann - Molecular Psychiatry 2015 cited by 142

  19. Comparative and Interactive Human Psychopharmacologic Effects of Ketamine and Amphetamine

    Authors: John H. Krystal, Edward Perry, Ralitza Gueorguieva, Ayşenil Belger, Steven Madonick, Anissa Abi‐Dargham, Thomas B. Cooper, Lisa Macdougall, Walid Abi‐Saab, Deepak Cyril D’Souza - Archives of General Psychiatry 2005 cited by 323

  20. Pharmacological Strategies in the Prevention of Relapse After Electroconvulsive Therapy

    Authors: Joan Prudic, Roger F. Haskett, W. Vaughn McCall, Keith Isenberg, Thomas B. Cooper, Peter B. Rosenquist, Benoit H. Mulsant, Harold A. Sackeïm - Journal of Ect 2013 cited by 106

  21. Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression

    Authors: Manesh Gopaldas, Francesca Zanderigo, Serena Zhan, R. Todd Ogden, Jeffrey M. Miller, Harry Rubin‐Falcone, Thomas B. Cooper, María A. Oquendo, Gregory M. Sullivan, J. John Mann, M. Elizabeth Sublette - Journal of Affective Disorders 2019 cited by 35

  22. Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats

    Authors: Bin Dong, B. M. Shilpa, Relish Shah, Arjun Goyal, Shan Xie, Mihran J. Bakalian, Raymond F. Suckow, Thomas B. Cooper, J. John Mann, Victoria Arango, K. Yaragudri Vinod - Journal of Psychiatric Research 2019 cited by 23

  23. Double-Blind and Placebo-Controlled Study of Lithium for Adolescent Bipolar Disorders With Secondary Substance Dependency

    Authors: Barbara Geller, Thomas B. Cooper, Kai Sun, Betsy Zimerman, Jeanne Frazier, Marlene Williams, Janet Heath - Journal of the American Academy of Child & Adolescent Psychiatry 1998 cited by 532

  24. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia

    Authors: Lawrence S. Kegeles, Anissa Abi‐Dargham, Yolanda Zea‐Ponce, Janine Rodenhiser‐Hill, J. John Mann, Ronald L. Van Heertum, Thomas B. Cooper, Arvid Carlsson, Marc Laruelle - Biological Psychiatry 2000 cited by 380